BIOGEN INC. (BIIB) /

The cash flow of BIOGEN INC. over the past 10 years

Chart BIOGEN INC.: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →

In fiscal 2025, the latest fiscal year on file, BIOGEN INC.'s operating cash flow was $2.2B and its capital expenditures $153.8M, leaving free cash flow of $2.05B. Free cash flow was above zero in all 10 years shown. It ranged from $1.14B in fiscal 2022 to $6.26B in fiscal 2019. Capital expenditures were highest in fiscal 2018, at $2.27B.

Year by year

Fiscal yearOperating cash flowCapital expendituresFree cash flow*
2025ended Dec 31, 2025$2.2B$153.8M$2.05B
2024ended Dec 31, 2024$2.88B$153.7M$2.72B
2023ended Dec 31, 2023$1.55B$277M$1.27B
2022ended Dec 31, 2022$1.38B$240.3M$1.14B
2021ended Dec 31, 2021$3.64B$258.1M$3.38B
2020ended Dec 31, 2020$4.23B$424.8M$3.81B
2019ended Dec 31, 2019$7.08B$814.5M*$6.26B
2018ended Dec 31, 2018$6.19B$2.27B*$3.92B
2017ended Dec 31, 2017$4.55B$2.07B*$2.48B
2016ended Dec 31, 2016$4.59B$1.82B*$2.77B

Fiscal years as BIOGEN INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on BIOGEN INC.

Companies of a similar size

Not investment advice. This page shows what BIOGEN INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.